Dennis L. McWilliams is the Chief Executive Officer of Apollo Endosurgery, Inc.  Mr. McWilliams has a broad base of entrepreneurial experience in both medical devices and drug therapies. Prior to Apollo‚ Mr. McWilliams was an Entrepreneur in Residence at PTV Sciences‚ a venture capital fund focusing on life science and medical devices.

Previously he co-founded Chrysalis BioTechnology‚ a development stage biopharmaceutical company focused on developing novel drug therapies for tissue regeneration‚ including bone‚ cartilage‚ and dermal soft tissue. As Chief Operating Officer‚ he was responsible for corporate financing‚ strategic partnering‚ and M&A activities‚ raising over $15 million in financing and the signing three major corporate partnerships. Chrysalis was acquired by OrthoLogic Corporation (NASDAQ: OLGC) in August 2004.

Prior to Chrysalis‚ Mr. McWilliams was a technology marketing specialist at the IC2 Institute ( Austin ‚ TX )‚ a technology "Think Tank" which implements strategies for technology commercialization. His projects included commercialization strategies for the University of Texas Medical Branch ‚ NASA‚ and CIA labs-including a project to apply missile tracking software to breast cancer detection. Mr. McWilliams received a Bachelor of Science with honors from the University of Texas and a Master of Science in Engineering Management from Stanford University. In 2007 he was given the Outstanding Young Texas Ex Award by the University of Texas.